1.19
price down icon9.16%   -0.12
after-market Dopo l'orario di chiusura: 1.19
loading

Prelude Therapeutics Inc Borsa (PRLD) Ultime notizie

pulisher
07:52 AM

Prelude Therapeutics appoints Katina Dorton to board of directors By Investing.com - Investing.com Canada

07:52 AM
pulisher
04:24 AM

How moving averages guide Prelude Therapeutics Incorporated tradingBull Run & Technical Entry and Exit Alerts - newser.com

04:24 AM
pulisher
09:04 AM

Prelude Therapeutics appoints Katina Dorton to board of directors - Investing.com

09:04 AM
pulisher
07:30 AM

Katina Dorton named to Prelude Therapeutics board and Audit Committee Chair, effective Oct. 17, 2025 - Stock Titan

07:30 AM
pulisher
07:19 AM

Is Prelude Therapeutics Incorporated stock a defensive play in 2025July 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com

07:19 AM
pulisher
Oct 15, 2025

Can Prelude Therapeutics Incorporated stock sustain free cash flow growth2025 Trading Recap & AI Forecasted Entry/Exit Points - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Can Prelude Therapeutics Incorporated stock maintain operating marginsCPI Data & Expert Approved Momentum Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How Prelude Therapeutics Incorporated stock reacts to oil pricesWeekly Trade Recap & Fast Entry High Yield Tips - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Is Prelude Therapeutics Incorporated stock supported by innovation pipelineEarnings Performance Report & Reliable Breakout Forecasts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Using Bollinger Bands to evaluate Prelude Therapeutics IncorporatedCEO Change & AI Forecasted Entry/Exit Points - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Prelude Therapeutics Incorporated stock deliver shareholder value2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:09:32 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can momentum traders help lift Prelude Therapeutics IncorporatedEarnings Summary Report & AI Driven Price Predictions - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Using economic indicators to assess Prelude Therapeutics Incorporated potentialFed Meeting & Safe Capital Allocation Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 02:10:25 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Analyzing Prelude Therapeutics Incorporated with risk reward ratio charts2025 Big Picture & Free Safe Capital Growth Stock Tips - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

CDK4/6 Inhibitor Market Positioned for Remarkable Growth as Revolutionary Therapies Transform Cancer Treatment Landscape in 2024 - Barchart.com

Oct 06, 2025
pulisher
Oct 05, 2025

Full technical analysis of Prelude Therapeutics Incorporated stock2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Prelude Therapeutics Incorporated rebound enough to break evenEarnings Risk Report & Fast Momentum Entry Tips - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Multi asset correlation models including Prelude Therapeutics IncorporatedInsider Buying & Weekly Watchlist for Consistent Profits - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will earnings trigger a reversal in Prelude Therapeutics IncorporatedPortfolio Return Summary & Verified Swing Trading Watchlists - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What drives Prelude Therapeutics Incorporated stock priceSector-Based Investing & Double Digit Trading Ideas - earlytimes.in

Oct 02, 2025
pulisher
Sep 28, 2025

Contrasting Cardiol Therapeutics (NASDAQ:CRDL) & Prelude Therapeutics (NASDAQ:PRLD) - Defense World

Sep 28, 2025
pulisher
Sep 27, 2025

Prelude Therapeutics (NASDAQ:PRLD) versus Talphera (NASDAQ:TLPH) Financial Contrast - Defense World

Sep 27, 2025
pulisher
Sep 26, 2025

3 Promising Penny Stocks With Over $60M Market Cap - simplywall.st

Sep 26, 2025
pulisher
Sep 26, 2025

Brokers Set Expectations for PRLD Q3 Earnings - Defense World

Sep 26, 2025
pulisher
Sep 24, 2025

Prelude Therapeutics’ (PRLD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

H.C. Wainwright reiterates Buy rating on Prelude Therapeutics stock with $5 target - Investing.com Canada

Sep 23, 2025
pulisher
Sep 23, 2025

Prelude Therapeutics (NASDAQ:PRLD) Receives Buy Rating from HC Wainwright - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

HC Wainwright & Co. Reiterates Buy Rating for PRLD, Price Target at $5.00 | PRLD Stock News - GuruFocus

Sep 23, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):